Coronavirus Vaccine: Would it help if you had the choice to choose your vaccine? | The Times of India

[ad_1]

Read More/Less


In the future weeks, there may come a time when we get to select the vaccine of our choice or the way we get it.

The differences, between vaccines, exist but are very small right now.

For example, a big distinction between the vaccines used right now is the manner in which they are made. mRNA vaccines (Moderna and Pfizer’s) use a novel approach to make antibodies in the body, whereas traditional vaccines (such as Oxford-Astrazeneca, Covaxin) use an inactive strain of the virus to train the immune system.

The vaccines being administrated right now are also mostly two-dose regimes, which work best when injected weeks apart. The only real difference is, while mRNA vaccines have a lower waiting time between the doses, traditional vaccines can be injected upto 6 weeks after the initial dose.

In comparison to them, Johnson and Johnson’s unique one-dose vaccine, which has just been recently won nods for usage may be a better selling point and a better option to choose when it is made available.

As for the side-effects, almost all of the COVID-19 vaccines are known to cause similar-ranging reactions which can be mild or moderate.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus live upates | Centre’s move to stop vaccine exports might affect U.K.: Adar Poonawalla

[ad_1]

Read More/Less


Maharashtra, Kerala and Punjab together account for 76.4% of active COVID-19 cases currently, with Maharashtra alone contributing nearly 60%, said data released by the Health Ministry on Wednesday.

You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.

Here are the latest updates:

Karnataka

Three new COVID-19 clusters emerge in Yelahanka zone in Bengaluru

Three new clusters have been detected in Yelahanka zone, taking the total number of active clusters to five. However, contact tracing is proving to be a nightmare as one family visited a temple despite being asked to remain in home isolation.

Among the new clusters, seven residents of an apartment in Vidyaranyapura ward have tested positive for COVID-19. The first positive case was detected on March 8 after a person returned from Kerala and developed symptoms. As a precautionary measure, BBMP health officials had advised other residents to stay indoors, even though they all initially tested negative.

However, one family went to ISKCON temple on March 9. The four family members developed symptoms on March 14 and tested positive the next day. On March 17, two more residents tested positive.

“We have intimated our counterparts in West zone. They will have to inform ISKCON authorities. It is very difficult to trace the secondary contacts, who may have visited the temple the same day as the family,” a health officer said.

Maharashtra

‘Rising cases may lead RBI to delay liquidity normalisation’

India’s central bank may have to delay the start of monetary policy normalisation by three months amid rising COVID-19 cases, but barring the return of stringent lockdowns there is no significant threat to the economy’s recovery, analysts say.

Having seen a peak of daily cases of almost 1,00,000 in late September, infections had been on a steady decline but have now started rising again over the last month.

“Even as the increase in the current caseload points to the risk of a second wave, more localised and less stringent restrictions will help contain the economic impact versus the initial wave,” said Radhika Rao, an economist with DBS Bank.

DBS has retained its assumptions for a stronger pick-up in March quarter growth versus the December 2020 quarter.

Karnataka

Karnataka govt. hospitals to ready 1,000 beds soon

With a second wave of COVID-19 outbreak imminent and three more clusters detected in Bengaluru on Thursday, the Karnataka government is gearing up to keep hospitals equipped.

As many as 1,000 COVID-19 beds will be readied in government hospitals and government medical colleges in the next 15 days, Health and Medical Education Minister K. Sudhakar said.

Addressing presspersons on Thursday after a meeting with senior health officials and heads of government hospitals and medical colleges, the Minister said he had asked all hospitals to keep beds ready on a mission mode. This apart, nearly 1,000 beds would also become functional from Monday in three COVID-19 care centres being set up in Bengaluru.

Gujarat

Amid rise in cases, Gujarat imposes additional curbs

The Gujarat government on Thursday imposed additional restrictions, including shutting down of schools and colleges, cancelling exams scheduled for college students and also shutting down malls/ shopping plazas and multiplexes on the weekends amidst rising COVID-19 cases in the second wave.

The State on Thursday recorded 1,276 cases and three deaths as the second wave of pandemic has struck, with alarming numbers of new infections in cities like Ahmedabad and Surat.

In Ahmedabad and Surat, the civic bodies have also increased the timing of night curfew from 9 p.m. to 6 a.m. while public transport bus services have been halted and all public parks, gardens and gyms have been shut in order to prevent people from gathering as the infection is surging.

New Delhi

Over 3.89 cr. vaccine doses administered so far: Centre

The cumulative number of COVID-19 vaccine doses administered in the country has crossed 3.89 crore on Thursday, the Union Health Ministry said on Thursday.

A total of 3,89,20,259 vaccine doses have been given, as per the provisional report till 7 p.m. on Thursday.

They include 76,19,786 to Health Care Workers (HCWs) who have taken the first dose and 46,92,962 HCWs who have taken the second dose, 78,11,126 Frontline Workers (FLWs) (first dose), 21,50,198 FLWs (second dose), 1,39,18,245 beneficiaries more than 60 years old and 27,27,942 beneficiaries aged 45 and above with specific co-morbidities.

A total of 17,83,303 vaccine doses have been given till 7 p.m. on Thursday, the 62nd day of nation-wide vaccination.

Tamil Nadu

Govt. hospitals get ready for surge in cases

With the number of fresh COVID-19 infections steadily rising in the city, the government hospitals are in a state of preparedness.

The infrastructure created was in place and the hospitals are gearing up to add more facilities and manpower in case of a surge.

The major government medical college hospitals set up exclusive COVID-19 facilities last year. As the number of fresh cases started to decline, the hospitals resumed their regular activities such as elective surgeries and outpatient services since October 2020.

In the last 10 days, the number of cases had been rising in Chennai. However, hospital authorities said the treatment facilities were intact.

The Netherlands

EU drug regulator backs AstraZeneca vaccine after safety investigation

The EU’s drug watchdog said on March 18 it is still convinced the benefits of AstraZeneca’s COVID-19 vaccine outweigh the risks following an investigation into reports of blood disorders that prompted more than a dozen nations to suspend its use.

The news came as the European Medicines Agency (EMA) director Emer Cooke said the agency could not definitively rule out a link to blood clot incidents and the vaccine in its investigation into 30 cases of a rare blood clotting condition. It will however update its guidance to include an explanation about the potential risks for doctors and the public, she said.

The agency has been under growing pressure to clear up safety concerns after a small number of reports in recent weeks of bleeding, blood clots and low platelet counts in people who have received the shot.

Telangana

File status report on COVID-19 measures by April 6, HC tells Telangana

Telangana High Court on Thursday sought to know what steps had the State government taken to keep a tab on incidence of COVID-19 in the recently opened schools and colleges.

Observing that these places witness huge gatherings in classes and students would be appearing for exams in coming days, a bench of Chief Justice Hima Kohli and Justice B. Vijaysen Reddy said that it was imperative that the State focused on this aspect. “We keep hearing that second wave of coronavirus had hit many countries and we don’t want our State to go that way,” the bench noted.

The Bench wanted to know what measures the State government had initiated to screen passengers entering Telangana from neighbouring States of Maharashtra and Karnataka which witnessed a spike in COVID-19 cases. Those entering the State through bus stations, railway stations and airport were having the potential to spread the virus.

Karnataka

Centre says no to vaccination points in old age homes, care facilities

The Centre has ruled out the possibility of COVID-19 vaccination centres (CVCs) in old age homes and long-term care facilities, as CVCs have to meet certain requirements to provide safe vaccination. This has irked authorities of old age homes and other long-term care facilities.

The Centre’s “No” follows a request from Karnataka seeking permission to set up CVCs beyond health facilities (such as old age homes, long-term care facilities, apartment complexes and identified polling booths) to ramp up vaccination coverage among the elderly.

In a letter dated March 17 addressed to Jawaid Akhtar, Additional Chief Secretary (Health and Family Welfare), Vandana Gurnani, Union Additional Secretary and Mission Director, National Health Mission (NHM), has said that CVCs should have adequate space for vaccination, adequate cold chain arrangements for vaccine storage, arrangements for management of Adverse Events Following Immunisation (AEFI).

“These facilities would then also need to be registered on CoWIN to enable session planning, reporting of AEFI and allocation of vaccines. Based on the analysis done from Co-WIN, it is observed that out of 460 private health facilities empanelled under Ayushman Bharat – Arogya Karnataka (AB-ArK) in the State, only 55 are registered on Co-WIN,” the letter stated.

France

France announces soft new virus restrictions in Paris region

The French government backed off from ordering a tough lockdown for Paris and several other regions despite an increasingly alarming situation at hospitals with a rise in the numbers of COVID-19 patients.

Instead, the Prime Minister on March 18 announced a patchwork of new restrictions while reducing the national curfew by one hour.

Getting large doses of fresh air is being encouraged, meaning that people living in the Paris region and in the north of the country can walk as long as they like in a day, but within a 10-kilometre (6-mile) radius of their homes and with a paper authorising the stroll.

Stores, however, will feel the pinch with all non-essential outlets — but not bookshops — closing down. And travel between regions is forbidden without a compelling reason.

Maharashtra

Centre’s move to stop vaccine exports might affect United Kingdom

With India, and particularly Maharashtra, witnessing a renewed surge in COVID-19 cases, the United Kingdom’s vaccination programme could hit a roadblock as the Indian government is temporarily staying exports to address the increased domestic vaccination demands.

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India (SII) which is manufacturing the Oxford-AstraZeneca vaccine, told the UK’s Telegraph newspaper that the situation was solely dependent on the Indian government and had nothing to do with the SII.

“It is solely dependent on India and it has nothing to do with the SII. It is to do with the Indian government allowing more doses to the U.K.,” Mr. Poonawalla told The Telegraph.

According to the paper, Mr. Poonawalla confirmed that five million doses of the Oxford vaccine had already been delivered to the U.K. early this month.

[ad_2]

READ FULL ARTICLE HERE

Morning Digest: Roads to be freed of toll booths in a year, says Nitin Gadkari; EU drug regulator backs AstraZeneca vaccine against COVID-19 after safety investigation, and more

[ad_1]

Read More/Less


India will implement a GPS-based toll collection system and do away with all toll booths within a year, Union Minister for Road Transport and Highways Nitin Gadkari informed the Lok Sabha on Thursday. He also shared details of the vehicle scrapping policy, first announced in the Union Budget for 2021-22, according to which the automobile industry in India will see a jump in turnover to ₹10 lakh crore from ₹4.5 lakh crore.

Chief Justice of India Sharad A. Bobde agreed with advocate Prashant Bhushan on Thursday to urgently hear a plea by NGO Association for Democratic Reforms to stay the sale of a new set of electoral bonds on April 1, before Assembly elections in crucial States such as West Bengal and Tamil Nadu.

Top U.S. and Chinese officials offered sharply different views of the world on March 18 as the two sides met face-to-face for the first time since President Joe Biden took office. In unusually pointed remarks for a staid diplomatic meeting, Secretary of State Antony Blinken and Chinese Communist Party foreign affairs chief Yang Jiechi took aim at each other’s policies at the start of two days of talks in Alaska.

The EU’s drug watchdog said on March 18 it is still convinced the benefits of AstraZeneca’s COVID-19 vaccine outweigh the risks following an investigation into reports of blood disorders that prompted more than a dozen nations to suspend its use.

The Rajya Sabha on Wednesday passed the Insurance Amendment Bill 2021 that increases the maximum foreign investment allowed in an insurance company from 49% to 74%, amid criticism from the Opposition parties on the clause enabling “control and ownership” by foreign investors.

The Supreme Court on Wednesday forbade judges from making gender stereotypical comments like “’good women are sexually chaste”, women who drink and smoke ‘ask’ for sexual advances or presume that a sexually active woman consented to rape while hearing cases of sexual offence.

Union Communications and Information Technology Minister Ravi Shankar Prasad said on Thursday that climate activist Disha Ravi’s arrest was based on law and order and it is under judicial process. He added that the House should consider “should some people abuse social media internationally to defame India to promote secessionism.”

Former Chief Economic Advisor (CEA) Arvind Subramanian resigned from Ashoka University on Thursday, days after noted columnist and political commentator Pratap Bhanu Mehta’s exit. In his resignation letter, Dr. Subramanian, said he had been “devastated” by “the circumstances involving the ‘resignation’ of Professor Pratap Bhanu Mehta” two days earlier.

In a major embarrassment to the Bharatiya Janata Party (BJP), two candidates announced by the party on Thursday for the Assembly polls from Kolkata have refused to contest on the party’s ticket.

The Supreme Court on Thursday stayed suo motu proceedings before the Delhi High Court on the administration of COVID-19 vaccine and transferred the case to itself. A Bench led by Chief Justice of India Sharad A. Bobde said a similar case concerning the vaccination drive was already pending in the Supreme Court, and the case from the Delhi High Court could be heard along with it.

The Supreme Court on Thursday agreed to urgently hear a plea to release and protect over 150 Rohingya refugees reportedly “detained” in Jammu. Chief Justice of India S.A. Bobde agreed to hear the application filed by a member of the Rohingya community, Mohammad Salimullah, represented by advocates Prashant Bhushan and Cheryl d’Souza, on April 25 (Thursday). Mr. Bhushan made an oral mention before the CJI for an early hearing.

The Lok Sabha on Thursday passed the supplementary demand for grants (second batch for 2020-21) but not before significant concerns raised by Opposition leaders on the government’s disinvestment and asset monetisation plans, and rising fuel prices.

If Ishan Kishan was unfortunate to be ruled out of the fourth T20I due to a groin strain, lady luck smiled on his replacement Suryakumar Yadav. The Mumbai cricketer, dropped for the previous outing after not having faced a ball on his debut in the second T20I, grabbed his chance and made it count.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

EU Regulator Says AstraZeneca Covid-19 Vaccine ‘Safe and Effective’, Not Linked to Blood Clot Risk

[ad_1]

Read More/Less


A nurse prepares to administer a dose of the AstraZeneca COVID-19 vaccine at a health care centre. (Image: AP)

A nurse prepares to administer a dose of the AstraZeneca COVID-19 vaccine at a health care centre. (Image: AP)

EMA chief Emer Cooke said its benefits in protecting people from Covid-19 with the associated risks of death and hospitalisation outweigh the possible risks.

  • AFP Amsterdam
  • Last Updated:March 18, 2021, 23:26 IST
  • FOLLOW US ON:

The EU’s drugs regulator said on Thursday that it had found the AstraZeneca coronavirus vaccine was “safe and effective” and was not linked to an increased risk of blood clots.

Around a dozen countries had suspended the use of the vaccine and were awaiting the outcome of an investigation by the European Medicines Agency (EMA) safety committee.

“The committee has come to a clear scientific conclusion: this is a safe and effective vaccine,” Emer Cooke, the head of the Amsterdam-based EMA, told a press conference.

“Its benefits in protecting people from Covid-19 with the associated risks of death and hospitalisation outweigh the possible risks,” she said.

“The committee also concluded that the vaccine is not associated with an increase in the overall risk of thromboembolic events or blood clots.” Cooke added: “If it was me I would be vaccinated tomorrow.” 

The EMA said however that it “could not rule out definitively” a connection to a particularly rare type of clotting disorder and would update the vaccine’s product information.

“During the investigation and review we began to see a small number of cases of rare and unusual but very serious clotting disorder and this then triggered a more focused review,” she said.

“Based on the evidence available, and after days of in depth analysis of lab results, clinical reports, autopsy reports and further information from the clinical trials, we still cannot rule out definitively a link between these cases and the vaccine.”

The new warning in the vaccine information would draw attention to the “possible rare conditions” to help patients and healthcare professionals “stop and mitigate any possible side effects.” The EMA was launching a further probe into the rare cases, she added.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus vaccine side-effects: 5 strange side-effects of the Oxford-Astrazeneca vaccine, apart from blood clotting

[ad_1]

Read More/Less


Side-effects with a vaccine are divided into three categories- very common, common and uncommon.

Uncommon or rare side-effects are the ones that affect one in a hundred people. Most people, through clinical testing and the current administration, have admittedly suffered from “common” side-effects, which are mild or moderate in nature and resolve in some days. These can range from chills, malaise, headache, tenderness, itching to muscle aches.

Uncommon ones can be sometimes mild, or severe and flag concerns. What exactly causes them is unclear, but some people can be predisposed to developing strange or allergic reactions.

Coming to the stranger side-effects witnessed by far, here’s what you should know:

[ad_2]

READ FULL ARTICLE HERE

Coronavirus vaccine: How long will the COVID vaccine stay effective? Here’s what doctors want you to know | The Times of India

[ad_1]

Read More/Less


COVID vaccines work to boost up the body’s immune response against the pathogen by generating antibodies that recognize and evade the infection in the future.

However, since it’s a new virus, and relatively a newer vaccine, there’s no real data to suggest how protected a person would really be, after getting vaccinated.

According to Dr Susheel Bindroo, Head of Dept. of Interventional Pulmonology, Jaslok Hospital & Research Centre, Mumbai, vaccine generated antibodies, or artificial immunity is always lower than natural immunity. He says, “In what we have observed so far, people do get COVID to observe natural neutralizing antibodies wane in a maximum of 6-7 months time. For some with serious comorbidities, it could go away even faster. Therefore, with caution, people must remember that even artificial immunity, at this point in time, would last for a relatively similar period. We cannot expect vaccines to work like magic.”

Dr Bharesh Dedhia, Consultant Critical Care, Hinduja Hospital Khar also opines that vaccines, while remaining to be one of the most effective tools right now, may not be as effective as we think them to be. “Considering the manner of mutations, it can happen that people need booster shots or be subjected to regular antibody testing to confirm how strong immunity is. “

Experts also feel that the track record with COVID trajectory and cases is very confusing, so there’s no real way to ascertain what could happen post-vaccination. Till now, neither of the companies, be it Moderna, Pfizer or Bharat Biotech have doled out recommendations or advisory on the same.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus | No lockdown, but fresh restrictions in place for Pune

[ad_1]

Read More/Less


The district currently has more than 17,000 active cases while the total death toll has exceeded 9,350.

While clarifying that no lockdown was imposed across Pune district, the administration on Friday said that all schools and colleges would remain closed till March 31 in wake of a heightened spike in cases.

Pune district has been recording the highest single-day jump in Maharashtra for the past few days, clocking up a daily average spike of more than 2,000 cases.

Following a review meeting between district Guardian Minister Ajit Pawar and senior district authorities in which Bharatiya Janata Party (BJP) MP Girish Bapat also present, Mr. Pawar directed the administration to curtail the operating time for hotels and restaurants as well.

“According to the new set of restrictions, schools and colleges will remain closed till March 31, while hotels and restaurants will be allowed to function at 50% of their total capacity till 10 p.m. Take-away food deliveries will be permitted for an hour after that till 11 p.m.,” informed Pune Divisional Commissioner Saurabh Rao.

He further said that it was mandatory for hotels to put up a board giving details about the occupancy in the premises at any given time.

Mr. Rao further informed that malls and cinema halls were to be kept closed after 10 p.m. while citizens would not be allowed to loiter on roads between 11 p.m. and 6 a.m. Only essential services are to be permitted during this time.

Given that MPSC exams are imminent, Mr. Rao said that MPSC coaching centres and libraries would be allowed to remain open with 50% occupancy.

The Divisional Commissioner said that rules for the number of people attending wedding functions remained the same (not more than 50 persons), while public transport services were to operate with 50% occupancy.

“Doctors and health workers are of the opinion that vaccination for Pune should get top priority in wake of soaring cases. They have opined that if we have to reduce the impact of the second wave, then vaccination is the best option. Since January 16 till today, the number of vaccination centres in the district have increased seven-fold from 33 to 208 with frontline workers largely covered in the first phase,” informed Mr. Rao, adding that the administration planned to restart the jumbo Covid-19 care facility sited at the College of Engineering Pune (CoEP) premises.

The district currently has more than 17,000 active cases while the total death toll has exceeded 9,350.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

Mild Post-Vaccine Reactions Are Unpleasant, But Maybe Reassuring That Immune System Is Responding

[ad_1]

Read More/Less


With several recipients of vaccines against the coronavirus complaining of side-effects post the shots, concerns are being raised about its impact on citizens. Vaccine beneficiaries have mostly complained of fever and fatigue. While for most, the issues fade after a day or two, some are facing trouble for longer hours.

According to a report in Bloomberg, typical symptoms include a sore arm, usually localised to the area the inoculation was given, and systemic symptoms, such as a mild fever or elevated temperature, headache and muscle aches. Studies have found younger adults reporting such reactions more frequently than elderly people (above 65 years).

The report further said that while the reactions may be unpleasant, they are usually short-lived and far less serious than what happens after a natural infection. Vaccines are extensively tested for safety before being released. Once they are administered on a large-scale bases, they are rigorously monitored in “post-marketing” surveillance systems for unexpected or rare reactions that are too uncommon to have been picked up in clinical trials. While adverse reactions to a vaccine are not uncommon, these products would not have received licences if they were likely to be severe or long-lasting.

The report said that feeling lousy after vaccination could be reassuring although there is not enough data to confirm it. At least, a mild, short-lived fever signals that the immune system is responding in a way that should confer protection against the coronavirus if it is encountered for real.

It said a slight fever below about 38.5 degrees Celsius (101 degrees Fahrenheit) is part of the body’s normal response to infection and is not harmful. If it can be tolerated, rest and fluids are the ideal remedy, said English. A sustained temperature above 39 degrees Celsius is more serious, especially in infants. Taking aspirin, acetaminophen/paracetamol (such as Tylenol), or a non-steroidal anti-inflammatory drug such as ibuprofen to relieve pain and fever is not likely to impair the quality of the immune response.

Reactions usually result from the immune system’s response to the key component — an antigen that resembles whatever bug it is designed to fight.

Normally, when a body encounters a bacteria, virus or some other potential foe, immune defences seek to neutralise and destroy it. Chemicals that attract cells to kill the invader are released in a process that can raise the body temperature, Peter English, a consultant in communicable disease control in the UK, was quoted as saying by Bloomberg. A vast army of so-called T cells and B cells are recruited to generate lasting “memory” of the foe and how to thwart it. “In learning to recognize the pathogen, the body goes through the same immune reactions as it would if it had met the pathogen for real, producing many of the same reactions,” English said.

Vaccines may also contain components that can induce a reaction, or enhance the immune response to the vaccine antigens, English said. Covid-19 vaccines may also include preservatives to prevent the vaccine from spoiling.

Regarding reactions being seen after the second dose, the report said it takes some time for the immune system to hone its response to a new pathogen. Immune memory cells are programmed such that when they encounter an invader a second time — either from a natural infection or vaccine antigens — they are primed to respond faster and more vigorously. That recognition typically triggers mass-production of immune-signaling molecules or “cytokines” that are responsible for the muscle aches, fevers, chills and fatigue recipients sometimes feel. The positive side of this is that the second encounter acts as a booster that should result in a more robust, longer-lasting immune response.

For those who have already survived the virus, their reaction to the shot may be more pronounced, but the benefits are likely to be so as well. Researchers have found antibody levels of those with pre-existing immunity were 10 to 45 times as high as those without at the same points in time after the first vaccine dose. Localised reactions to the vaccine occurred with equal frequency in both groups at the time of vaccination and resolved spontaneously days later. However, systemic side effects, like such as fatigue, headache, chills, fever and muscle aches, occurred after vaccination in 89% of those with pre-existing immunity compared with 46% of recipients without any.

[ad_2]

READ FULL ARTICLE HERE

Coronavirus | India records 18,327 new COVID-19 infections, active cases rise again

[ad_1]

Read More/Less


The COVID-19 active caseload has increased to 1,80,304 which now comprises 1.61% of the total infections

India’s COVID-19 tally rose to 1,11,92,088 with over 18,000 fresh cases being reported in a span of 24 hours in the country after 36 days, while active cases registered an increase for the fourth consecutive day on March 6 and were recorded at 1,80,304, according to the Union Health Ministry.

The death toll reached 1,57,656 with 108 more fatalities, while a total of 18,327 new cases were registered in a day, the Ministry’s data showed.

On January 29, 18,855 new infections were recorded in a span of 24 hours after which the daily rise in fresh cases remained below 18,000.

The number of people who have recuperated from the disease surged to 1,08,54,128 which translates to a national COVID-19 recovery rate of 96.98%, while the case fatality rate stands at 1.41%.

The COVID-19 active caseload has increased to 1,80,304 which now comprises 1.61% of the total infections.

India’s COVID-19 tally had crossed the 20 lakh-mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one crore-mark on December 19.

According to the ICMR, 22,06,92,677 samples have been tested up to March 5 with 7,51,935 samples being tested on March 5.

The 108 new fatalities include 53 from Maharashtra, 16 from Kerala and 11 from Punjab.

A total of 1,57,656 deaths have been reported so far in the country, including 52,393 from Maharashtra followed by 12,513 from Tamil Nadu, 12,354 from Karnataka, 10,918 from Delhi, 10,275 from West Bengal, 8,729 from Uttar Pradesh and 7,172 from Andhra Pradesh.

The Health Ministry stressed that more than 70% of the deaths occurred due to comorbidities.

“Our figures are being reconciled with the Indian Council of Medical Research,” the Ministry said on its website, adding that State-wise distribution of figures is subject to further verification and reconciliation.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

[ad_2]

READ FULL ARTICLE HERE

‘Can Get Vaccinated 24×7 at Your Convenience’: Govt Removes Time Constraint for Getting Covid-19 Shot

[ad_1]

Read More/Less


Hospitals can extend or advance the vaccination schedule any day and do not have to stick to a fixed schedule to inoculate people against Covid-19 and, the government has said, in a move that will help speed up the vaccination drive.

“The government has removed time constraint to increase the speed of vaccination. People can get vaccinated 24×7 at their convenience. Prime Minister Narendra Modi understands the value of both time and health of citizens,” Health Minister Harsh Vardhan tweeted, replying to a report by a newspaper.

Since all hospitals, both private and government ones, are linked by the government’s CoWIN app and website, the flexible schedule allowed by the government is applicable to both.

The Centre on Tuesday permitted all private hospitals to give Covid-19 vaccine if they adhere to the laid down norms and also asked the states and union territories to utilise the optimum capacity of private medical facilities empanelled under three categories.

The states and Union territories were also urged not to store, reserve, conserve or create a buffer stock of the COVID-19 vaccines, the Union Health ministry said in a statement, a day after the start of the second phase of India’s inoculation drive in which the coverage has been expanded to include everyone above 60 and those over 45 with specified co-morbidities.

At an official review meeting with the states, the Centre reiterated there is no shortage of the vaccines and hence, adequate vaccine doses should be allocated to the COVID Vaccination Centres(CVCs) “The central government has adequate stock and will provide the required vaccine doses to the states and UTs,” it said.

The Centre urged the states and the UTs to ensure adequate allocation of COVID-19 vaccines to all hospitals, government as well as private, for the entire duration for which vaccination sessions have been planned. It asked them to utilise the optimum capacity of all private hospitals empanelled under the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), the Central Government Health Scheme (CGHS) and the state health insurance schemes to enable them to effectively function as CVCs.



[ad_2]

READ FULL ARTICLE HERE